Published in TB and Outbreaks Week, October 10th, 2006
Study 1: Antibodies can modify various aspects of mycobacterial infection to benefit the host.
According to a recent review from the United States, "Antibody-mediated immunity has been historically considered to have no rote in host-defense against Mycobacterium tuberculosis. In recent years, studies from our group as well as others have challenged this traditional thinking."
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of TB and Outbreaks Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.